Shire Viropharma Inc (VPHM)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: VPHM Exchange: NSQ


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2012-12-27 2012-12-24 PS Planned sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
17,500 -31.7%
22.53
394,301 USD 		17,500 -31.7% 22.53 394,301 USD
2012-12-17 2012-12-13 S Sale

BROOKE PAUL A

Non-Executive Director
60,000 -36.5%
23.87
1,431,954 USD 		60,000 -36.5% 23.87 1,431,954 USD
2012-12-12 2012-12-10 PS Planned sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
14,999 -28.5%
24.07
360,984 USD 		14,999 -28.5% 24.07 360,984 USD
2012-12-12 2012-12-10 S Sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
50,000 -57.0%
24.07
1,203,360 USD 		50,000 -57.0% 24.07 1,203,360 USD
2012-12-12 2012-12-10 S Sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
10,000 -21.0%
24.07
240,672 USD 		10,000 -21.0% 24.07 240,672 USD
2012-12-05 2012-12-03 S Sale

Wolf John Peter III

VP, General Counsel

Officer
18,000 -100.0%
24.85
447,257 USD 		18,000 -100.0% 24.85 447,257 USD
2012-12-05 2012-12-03 B Purchase

DOUGHERTY MICHAEL R

Non-Executive Director
2,500 +55.6%
25.07
62,675 USD 		2,500 +55.6% 25.07 62,675 USD
2012-12-05 2012-12-03 S Sale

CLAYPOOL WILLIAM D MD

Non-Executive Director
10,000 -18.3%
24.80
248,000 USD 		10,000 -18.3% 24.80 248,000 USD
2012-12-04 2012-11-30 S Sale

GLASER ROBERT

Non-Executive Director
10,000 -19.5%
24.78
247,795 USD 		10,000 -19.5% 24.78 247,795 USD
2012-12-04 2012-11-30 S Sale

GLASER ROBERT

Non-Executive Director
20,000 -32.6%
24.78
495,590 USD 		20,000 -32.6% 24.78 495,590 USD
2012-11-30 2012-11-28 S Sale

CLAYPOOL WILLIAM D MD

Non-Executive Director
15,000 -21.6%
24.22
363,326 USD 		15,000 -21.6% 24.22 363,326 USD
2012-11-30 2012-11-28 S Sale

CLAYPOOL WILLIAM D MD

Non-Executive Director
2,500 -4.4%
24.22
60,554 USD 		2,500 -4.4% 24.22 60,554 USD
2012-11-15 2012-11-13 S Sale

CLAYPOOL WILLIAM D MD

Non-Executive Director
12,500 -18.7%
25.01
312,585 USD 		12,500 -18.7% 25.01 312,585 USD
2012-11-15 2012-11-13 S Sale

CLAYPOOL WILLIAM D MD

Non-Executive Director
10,000 -15.5%
24.84
248,426 USD 		10,000 -15.5% 24.84 248,426 USD
2012-11-13 2012-11-08 S Sale

MILANO VINCENT

President and CEO

Executive Director
41,418 -30.5%
24.54
1,016,522 USD 		41,418 -30.5% 24.54 1,016,522 USD
2012-11-13 2012-11-08 S Sale

MILANO VINCENT

President and CEO

Executive Director
42,000 -30.8%
24.54
1,030,806 USD 		42,000 -30.8% 24.54 1,030,806 USD
2012-11-05 2012-11-02 S Sale

CLAYPOOL WILLIAM D MD

Non-Executive Director
10,000 -15.5%
25.37
253,703 USD 		10,000 -15.5% 25.37 253,703 USD
2012-06-13 2012-06-11 S Sale

CLAYPOOL WILLIAM D MD

Non-Executive Director
10,000 -13.4%
20.04
200,430 USD 		10,000 -13.4% 20.04 200,430 USD
2012-03-27 2012-03-23 PS Planned sale

Pietrusko Robert

VP, Regulatory & Quality

Officer
20,000 -82.9%
30.00
600,000 USD 		20,000 -82.9% 30.00 600,000 USD
2012-03-12 2012-03-09 S Sale

Morris Richard Steven

Chief Accounting Officer

Officer
1,300 -51.1%
29.71
38,618 USD 		1,300 -51.1% 29.71 38,618 USD
2012-03-12 2012-03-09 S Sale

Fletcher Robert C.

V.P., Business Development

Officer
32,000 -99.3%
29.65
948,954 USD 		32,000 -99.3% 29.65 948,954 USD
2012-03-07 2012-03-05 S Sale

Morris Richard Steven

Chief Accounting Officer

Officer
5,300 -81.0%
33.01
174,953 USD 		5,300 -81.0% 33.01 174,953 USD
2012-03-07 2012-03-05 S Sale

DOYLE THOMAS F

VP Strategic Initiatives

Officer
210,000 -80.0%
32.48
6,820,212 USD 		210,000 -80.0% 32.48 6,820,212 USD
2012-03-06 2012-03-01 S Sale

SOLAND DANIEL B

VP, Chief Operating Officer

Officer
30,000 -41.2%
32.99
989,700 USD 		30,000 -41.2% 32.99 989,700 USD
2012-03-05 2012-03-01 S Sale

Rowland Charles A Jr

VP, Chief Financial Officer

Officer
12,750 -42.7%
32.11
409,434 USD 		12,750 -42.7% 32.11 409,434 USD
2012-03-05 2012-03-01 S Sale

Rowland Charles A Jr

VP, Chief Financial Officer

Officer
70,000 -70.1%
32.12
2,248,197 USD 		70,000 -70.1% 32.12 2,248,197 USD
2011-12-16 2011-12-14 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
50,566 +2.6%
27.29
1,379,860 USD 		50,566 +2.6% 27.29 1,379,860 USD
2011-12-16 2011-12-14 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
291,706 +3.1%
27.29
7,960,161 USD 		291,706 +3.1% 27.29 7,960,161 USD
2011-12-16 2011-12-14 B Purchase

14159 capital (GP), LLC

Large shareholder
7,828 +2.6%
27.29
213,613 USD 		7,828 +2.6% 27.29 213,613 USD
2011-12-15 2011-12-14 PS Planned sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
25,000 -56.3%
25.17
629,250 USD 		25,000 -56.3% 25.17 629,250 USD
2011-12-15 2011-12-14 PS Planned sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
25,000 -56.3%
25.50
637,500 USD 		25,000 -56.3% 25.50 637,500 USD
2011-12-14 2011-12-13 PS Planned sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
22,330 -53.5%
23.50
524,755 USD 		22,330 -53.5% 23.50 524,755 USD
2011-12-14 2011-12-12 PS Planned sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
17,670 -47.6%
23.50
415,317 USD 		17,670 -47.6% 23.50 415,317 USD
2011-12-05 2011-12-01 S Sale

DOYLE THOMAS F

VP Strategic Initiatives

Officer
10,000 -16.0%
23.82
238,159 USD 		10,000 -16.0% 23.82 238,159 USD
2011-12-01 2011-11-30 PS Planned sale

Pietrusko Robert

VP, Regulatory & Quality

Officer
20,000 -83.6%
24.00
480,000 USD 		20,000 -83.6% 24.00 480,000 USD
2011-11-29 2011-11-28 PS Planned sale

Pietrusko Robert

VP, Regulatory & Quality

Officer
19,000 -82.9%
23.00
437,000 USD 		19,000 -82.9% 23.00 437,000 USD
2011-11-29 2011-11-28 S Sale

GLASER ROBERT

Non-Executive Director
5,000 -11.9%
23.00
115,000 USD 		5,000 -11.9% 23.00 115,000 USD
2011-11-28 2011-11-23 PS Planned sale

Pietrusko Robert

VP, Regulatory & Quality

Officer
1,000 -25.6%
23.00
23,000 USD 		1,000 -25.6% 23.00 23,000 USD
2011-11-23 2011-11-21 PS Planned sale

MILANO VINCENT

President and CEO

Executive Director
41,691 -35.4%
22.53
939,127 USD 		41,691 -35.4% 22.53 939,127 USD
2011-11-23 2011-11-21 PS Planned sale

MILANO VINCENT

President and CEO

Executive Director
19,996 -20.8%
22.53
450,428 USD 		19,996 -20.8% 22.53 450,428 USD
2011-11-23 2011-11-21 PS Planned sale

MILANO VINCENT

President and CEO

Executive Director
15,000 -16.4%
22.53
337,889 USD 		15,000 -16.4% 22.53 337,889 USD
2011-11-17 2011-11-16 S Sale

Morris Richard Steven

Chief Accounting Officer

Officer
2,000 -63.2%
22.59
45,181 USD 		2,000 -63.2% 22.59 45,181 USD
2011-11-15 2011-11-14 PS Planned sale

Pietrusko Robert

VP, Regulatory & Quality

Officer
20,000 -83.6%
22.00
440,000 USD 		20,000 -83.6% 22.00 440,000 USD
2011-11-09 2011-11-07 S Sale

Wolf John Peter III

VP, General Counsel

Officer
12,250 -100.0%
21.08
258,194 USD 		12,250 -100.0% 21.08 258,194 USD
2011-11-08 2011-11-07 S Sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
200 -1.0%
21.01
4,202 USD 		200 -1.0% 21.01 4,202 USD
2011-11-08 2011-11-07 S Sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
19,800 -50.2%
21.00
415,800 USD 		19,800 -50.2% 21.00 415,800 USD
2011-11-02 2011-11-01 PS Planned sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
24,121 -55.4%
20.05
483,641 USD 		24,121 -55.4% 20.05 483,641 USD
2011-11-02 2011-10-31 S Sale

Broom Colin MD

VP & Chief Scientific Officer

Officer
20,495 -51.3%
20.42
418,555 USD 		20,495 -51.3% 20.42 418,555 USD
2011-10-06 2011-10-05 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
145,763 +1.6%
18.18
2,650,423 USD 		145,763 +1.6% 18.18 2,650,423 USD
2011-10-06 2011-10-05 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
16,278 +0.9%
18.18
295,985 USD 		16,278 +0.9% 18.18 295,985 USD
2011-10-06 2011-10-05 B Purchase

14159 capital (GP), LLC

Large shareholder
6,017 +2.1%
18.18
109,408 USD 		6,017 +2.1% 18.18 109,408 USD
2011-10-06 2011-10-04 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
45,584 +0.5%
17.48
796,644 USD 		45,584 +0.5% 17.48 796,644 USD
2011-10-06 2011-10-04 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
2,511 +0.1%
17.48
43,883 USD 		2,511 +0.1% 17.48 43,883 USD
2011-10-06 2011-10-04 B Purchase

14159 capital (GP), LLC

Large shareholder
1,905 +0.7%
17.48
33,293 USD 		1,905 +0.7% 17.48 33,293 USD
2011-10-03 2011-10-03 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
445,574 +5.0%
17.71
7,890,269 USD 		445,574 +5.0% 17.71 7,890,269 USD
2011-10-03 2011-10-03 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
70,629 +0.8%
17.62
1,244,589 USD 		70,629 +0.8% 17.62 1,244,589 USD
2011-10-03 2011-09-30 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
88,657 +1.0%
18.08
1,602,892 USD 		88,657 +1.0% 18.08 1,602,892 USD
2011-10-03 2011-09-30 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
43,321 +0.5%
18.19
788,122 USD 		43,321 +0.5% 18.19 788,122 USD
2011-10-03 2011-09-30 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
13,576 +0.7%
18.08
245,450 USD 		13,576 +0.7% 18.08 245,450 USD
2011-10-03 2011-09-30 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
6,634 +0.4%
18.19
120,690 USD 		6,634 +0.4% 18.19 120,690 USD
2011-10-03 2011-09-30 B Purchase

14159 capital (GP), LLC

Large shareholder
3,367 +1.2%
18.08
60,874 USD 		3,367 +1.2% 18.08 60,874 USD
2011-10-03 2011-09-30 B Purchase

14159 capital (GP), LLC

Large shareholder
1,645 +0.6%
18.19
29,927 USD 		1,645 +0.6% 18.19 29,927 USD
2011-10-03 2011-09-29 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
159,945 +1.9%
18.00
2,878,882 USD 		159,945 +1.9% 18.00 2,878,882 USD
2011-10-03 2011-09-29 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
21,117 +1.1%
18.00
380,089 USD 		21,117 +1.1% 18.00 380,089 USD
2011-10-03 2011-09-29 B Purchase

14159 capital (GP), LLC

Large shareholder
6,084 +2.2%
18.00
109,507 USD 		6,084 +2.2% 18.00 109,507 USD
2011-10-03 2011-09-29 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
89,970 +1.1%
17.97
1,616,392 USD 		89,970 +1.1% 17.97 1,616,392 USD
2011-10-03 2011-09-29 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
11,878 +0.6%
17.97
213,399 USD 		11,878 +0.6% 17.97 213,399 USD
2011-10-03 2011-09-29 B Purchase

14159 capital (GP), LLC

Large shareholder
3,423 +1.3%
17.97
61,497 USD 		3,423 +1.3% 17.97 61,497 USD
2011-09-26 2011-09-26 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
4,697 +0.3%
18.13
85,155 USD 		4,697 +0.3% 18.13 85,155 USD
2011-09-26 2011-09-26 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
22,084 +1.2%
18.13
400,295 USD 		22,084 +1.2% 18.13 400,295 USD
2011-09-26 2011-09-26 B Purchase

14159 capital (GP), LLC

Large shareholder
1,103 +0.4%
18.13
19,997 USD 		1,103 +0.4% 18.13 19,997 USD
2011-09-26 2011-09-26 B Purchase

14159 capital (GP), LLC

Large shareholder
5,184 +1.9%
18.13
93,965 USD 		5,184 +1.9% 18.13 93,965 USD
2011-09-26 2011-09-26 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
28,000 +0.3%
18.13
507,632 USD 		28,000 +0.3% 18.13 507,632 USD
2011-09-26 2011-09-26 B Purchase

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
131,641 +1.6%
18.13
2,386,125 USD 		131,641 +1.6% 18.13 2,386,125 USD
2011-09-26 2011-09-23 B Purchase

Baker Biotech Capital (GP), LLC

Large shareholder
8,828 +0.5%
17.78
156,988 USD 		8,828 +0.5% 17.78 156,988 USD